Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization

Despite extensive use of intravitreal anti-vascular endothelial growth factor (anti-VEGF) biologics for over a decade, neovascular age-related macular degeneration (nAMD) or choroidal neovascularization (CNV) continues to be a major cause of irreversible vision loss in developed countries. Many nAMD...

Full description

Bibliographic Details
Main Authors:	Yingbin Fu, Zhao Zhang, Keith A. Webster, Yannis M. Paulus
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Biomolecules
Subjects:	choroidal neovascularization CNV anti-VEGF resistance neovascular age-related macular degeneration AMD arteriolar CNV
Online Access:	https://www.mdpi.com/2218-273X/14/3/252

Similar Items

Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD)
by: Vivian Paraskevi Douglas, et al.
Published: (2022-04-01)

Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization
by: Steven Droho, et al.
Published: (2020-11-01)

A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression
by: Shan Liu, et al.
Published: (2020-06-01)

Immunosenescence in Choroidal Neovascularization (CNV)—Transcriptional Profiling of Naïve and CNV-Associated Retinal Myeloid Cells during Aging
by: Anja Schlecht, et al.
Published: (2021-12-01)

Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy
by: Mayank Choubey, et al.
Published: (2023-06-01)

Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice
by: Hu W, et al.
Published: (2024-01-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01)

Transpupillary Thermotherapy for Treatment of Choroidal Neovascularisation Secondary to Age-Related Macular Degeneration in Indian Eyes
by: Nagpal Manish, et al.
Published: (2003-01-01)

LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration
by: Lucia Mundo, et al.
Published: (2021-08-01)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
by: Henrik Faatz, et al.
Published: (2022-11-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
by: Pongsachareonnont P, et al.
Published: (2018-09-01)

Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration
by: Joseph B. Lin, BS, et al.
Published: (2024-03-01)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021-06-01)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021-10-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Inhibition of Ocular Neovascularization by Co-Inhibition of VEGF-A and PLGF
by: Xiaochuan Huo, et al.
Published: (2015-03-01)

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration
by: Hageman Gregory S, et al.
Published: (2011-07-01)

Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model
by: Ramin Nourinia, et al.
Published: (2014-01-01)

OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments
by: Davide Allegrini, et al.
Published: (2022-08-01)

Intravitreal Ranibizumab for Subfoveal Choroidal Neovascularization from Age-Related Macular Degeneration with Combined Severe Diabetic Retinopathy
by: So Young Han, et al.
Published: (2015-02-01)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Elliott H. Sohn, MD, et al.
Published: (2021-03-01)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
by: Yan Lu, et al.
Published: (2021-11-01)

Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
by: Federico Ricci, et al.
Published: (2020-11-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
by: Avaylon J, et al.
Published: (2020-05-01)

Asymmetric response to ranibizumab in mixed choroidal neovascularization in a neovascular age-related macular degeneration diagnosed on OCT angiography – case report
by: Martin Pencak, et al.
Published: (2021-01-01)

Blocking Ocular Sympathetic Activity Inhibits Choroidal Neovascularization
by: Juan Carlos Martinez-Camarillo, et al.
Published: (2022-01-01)

Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
by: Ahmed M. Hagag, et al.
Published: (2020-06-01)

Usefulness of optical coherence tomography angiography in choroidal neovascularization secondary to neovascular age-related macular degeneration
by: Mayur S Kulkarni, et al.
Published: (2020-01-01)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
by: Akira Hirata, et al.
Published: (2018-03-01)

The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
by: I-Chia Liang, et al.
Published: (2021-11-01)

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model
by: Anna Salas, et al.
Published: (2023-09-01)

Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01)

Results of Intravitreal Anti-VEGF Injection in Choroidal Neovascularization Caused by Pathologies Other Than Age-Related Macular Degeneration
by: Mehmet Ozveren
Published: (2020-08-01)

Proteotranscriptomic analyses reveal distinct interferon-beta signaling pathways and therapeutic targets in choroidal neovascularization
by: Yuxiang Hu, et al.
Published: (2023-03-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
by: Sanjay Kumar Mishra, et al.
Published: (2022-07-01)

Microglial repopulation restricts ocular inflammation and choroidal neovascularization in mice
by: Yinting Song, et al.
Published: (2024-04-01)

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up
by: Rosalia Giustolisi, et al.
Published: (2014-09-01)